Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kate Heinrich Oswell
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
ORCID:
0009-0004-8997-4756
Observed ORCID:
0009-0004-8997-4756
OpenAlex ID:
A5119947047
Patient Perceptions of and Experiences with Risk Evaluation and Mitigation Strategies
2025
·
Ameet Sarpatwari
, Su Been Lee
, et al.
·
Clinical Pharmacology & Therapeutics
·
3
Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials
2025
·
Susan Chimonas
, Carol Cosenza
, et al.
·
Drug Safety
·
2
PDF
Physician Understanding and Perceptions of Risk Communication Related to Drugs Covered by Risk Evaluation and Mitigation Strategy Programs
2026
·
Heidi Zakoul
, Carol Cosenza
, et al.
·
Pharmacoepidemiology and Drug Safety
PDF
Communicating Drug Safety and Safe Use Conditions in Risk Evaluation and Mitigation Strategy Materials
2026
·
Ameet Sarpatwari
, Frazer A. Tessema
, et al.
·
Drug Safety
Show more works
View as search
Works count:
4
Citation count:
5
H-index:
2
I10-index:
Year
Topic
Type